Glioblastoma in natalizumab‐treated multiple sclerosis patients

We present two natalizumab‐treated multiple sclerosis patients who developed glioblastoma multiforme (GBM) with variable outcomes. One patient had an isocitrate dehydrogenase (IDH)‐wildtype GBM with aggressive behavior, who declined treatment and died 13 weeks after symptoms onset. The other patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Clin Transl Neurol
Main Authors: Sierra Morales, Fabian, Wright, Robert B., Novo, Jorge E., Arvanitis, Leonidas D., Stefoski, Dusan, Koralnik, Igor J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Brief Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497532/
https://ncbi.nlm.nih.gov/pubmed/28695151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.428
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados